28 January 2026
Solving the Silicone Challenge in Pre-fillable Syringes

Developing biologic drugs, especially injectable formulations, presents unique challenges. Stevanato Group’s Alba® syringe platform introduces a plasma-treated silicone coating designed to enhance stability and reduce interaction with drug products. Comparative stability studies between traditional silicone oil syringes and Alba® suggest improved performance over time. These findings indicate that Alba® may offer a promising option for maintaining biologic drug integrity during storage and use. Download the white paper to learn more.
Download the Full White Paper Here!
Download the Full e-Book Here!
DownloadDownload the Full Interview Here!
DownloadSubscribe For News Updates
Subscribe to the IMAPAC Newsletter to stay informed of the latest news in the biopharmaceutical industry.
